Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator. [electronic resource]
Producer: 20120426Description: 133-7 p. digitalISSN:- 1434-9949
- Adalimumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Etanercept
- Female
- Health Status Indicators
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.